Hepatitis E vaccine:  WHO position paper, May 2015.
D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D003906:Developing Countries; D005260:Female; D005838:Genotype; D006508:Hepatitis Antibodies / Q000276:immunology; D016751:Hepatitis E / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D016752:Hepatitis E virus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control / Q000821:virology; D012306:Risk; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D014944:World Health Organization
D036022:Capsid Proteins; D006508:Hepatitis Antibodies; D014761:Viral Hepatitis Vaccines